Detailed analysis of immune response to SARS-CoV-2 bodes well for COVID-19 vaccine

(La Jolla Institute for Immunology) A new study documents a robust antiviral immune response to SARS-CoV-2 in a group of 20 adults who had recovered from COVID-19. The findings show that the body's immune system is able to recognize SARS-CoV-2 in many ways, dispelling fears that the virus may elude ongoing efforts to create an effective vaccine.